Yoon Seok Koh

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Sex Differences in Outcomes Following Endovascular Treatment for Symptomatic Peripheral Artery Disease: An Analysis From the K‐VIS ELLA Registry

Ki Hong Choi, Taek Kyu Park, Jihoon Kim et al. · Journal of the American Heart Association · 2019 · 57 citations · Full text

Hypertension, Endovascular Technique, Surgery +23

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention

Suk Min Seo, Eun Ho Choo, Yoon Seok Koh et al. · Heart · 2011 · 51 citations · Full text

Randomized Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total Occlusion

Hun‐Jun Park, Hee-Yeol Kim, Jong Min Lee et al. · Circulation Journal · 2012 · 46 citations · Full text